Mediterranean diet, gut microbiota, and type 2 diabetes: A systematic review and meta-analysis of intervention trials
Nutrition, Metabolism and Cardiovascular Diseases · 2026-05 · 36 (5) · 104433
DOI: 10.1016/j.numecd.2025.104433 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026-05. Verfasst von Fabio Lauria und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Food Sciences, National Research Council (CNR), Avellino, Italy. Hauptthemen laut MEDLINE: Diet, Mediterranean, Diabetes Mellitus, Type 2, Gastrointestinal Microbiome, Cardiovascular Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, European Commission, Ministero dell'Università e della Ricerca.
Themen: Diabetes mellitus
Abstract (Originalsprache)
AIMS: The Mediterranean diet (MedD) is associated with improved metabolic health and modulation of gut microbiota (GM), both relevant to preventing type 2 diabetes (T2D) and cardiovascular disease (CVD). This systematic review and meta-analysis evaluated the effects of MedD-based dietary interventions on metabolic outcomes and GM composition in individuals at increased risk of T2D and CVD. DATA SYNTHESIS: We searched PubMed, Embase, Web of Science, Cochrane CENTRAL, and Scopus up to October 11, 2024, for randomized controlled trials (RCTs) comparing MedD-based diets to control diets in adults. Studies reporting outcomes on glucose metabolism and GM composition were included. Random-effects meta-analyses were conducted on metabolic outcomes. GM findings were synthesized descriptively due to heterogeneity in sequencing methods and taxonomic reporting. Nine RCTs (n = 1337 participants) met the inclusion criteria. Compared with control diets, MedD interventions significantly reduced glycated hemoglobin (HbA1c) (mean difference -0.18, 95 % CI = -0.35, -0.01), LDL cholesterol (-0.10, 95 % CI = -0.19, -0.00), and triglycerides -0.20, 95 % CI = -0.28, -0.12). No significant effects were observed on fasting glucose, insulin, HOMA-IR, total cholesterol, or HDL cholesterol. A qualitative GM analysis showed increased α-diversity and enrichment of health-related taxa, including Akkermansia muciniphila and Roseburia spp. CONCLUSIONS: Our findings suggest that MedD interventions improve HbA1c, LDL cholesterol, and triglycerides, and promote beneficial GM changes. These may contribute to the metabolic benefits of the MedD. Future research should focus on individualized approaches, longer intervention periods, and mechanistic insights using multi-omics data to better understand the diet-microbiota-host interaction. PROTOCOL REGISTRATION: PROSPERO as CRD42023428016.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Food Sciences, National Research Council (CNR), Avellino, Italy.
- Institute of Food Sciences, National Research Council (CNR), Avellino, Italy; Nutrition, Diabetes and Metabolism Research Unit, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
- Institute of Food Sciences, National Research Council (CNR), Avellino, Italy. Electronic address: carmela.spagnuolo@cnr.it.
- Nutrition, Diabetes and Metabolism Research Unit, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Förderung
- Ministero dell’Istruzione, dell’Università e della Ricerca
- European Commission
- Ministero dell'Università e della Ricerca
- CNR
Zitieren
APA
Lauria, F., Formisano, A., Dello Russo, M., Quaglia, C., Giacco, R., Russo, G. L., Spagnuolo, C., & Vitale, M. (2026). Mediterranean diet, gut microbiota, and type 2 diabetes: A systematic review and meta-analysis of intervention trials. Nutrition, Metabolism and Cardiovascular Diseases, 36(5), 104433. https://doi.org/10.1016/j.numecd.2025.104433
Vancouver
Lauria F, Formisano A, Dello Russo M, Quaglia C, Giacco R, Russo GL, et al. Mediterranean diet, gut microbiota, and type 2 diabetes: A systematic review and meta-analysis of intervention trials. Nutrition, Metabolism and Cardiovascular Diseases. 2026;36(5):104433. doi:10.1016/j.numecd.2025.104433
BibTeX
@article{Lauria2026,
author = {Lauria, Fabio and Formisano, Annarita and Dello Russo, Marika and Quaglia, Cinzia and Giacco, Rosalba and Russo, Gian Luigi and Spagnuolo, Carmela and Vitale, Marilena},
title = {Mediterranean diet, gut microbiota, and type 2 diabetes: A systematic review and meta-analysis of intervention trials},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2026},
volume = {36},
number = {5},
pages = {104433},
doi = {10.1016/j.numecd.2025.104433}
}
EUVIMED